Newsfeeds Archive - Page 99 of 696

2 minute read

August 16, 8:05 AM

Shiba Inu, German Shepherd, Golden Retriever, and Schnauzer are the first breeds to launch using novel machine learning framework that replicates life-like interactions and training DatChat (NASDAQ:DATS), announced

DATS

2 minute read

PDS Biotech Announces Data From IMMUNOCERV Phase 2 Trial Investigating PDS0101 And Chemoradiotherapy In Cervical Cancer To Be Featured In Oral Presentation At The ASTRO 2023 Annual Meeting

By Happy Mohamed

August 16, 8:05 AM

PDS Biotechnology Corporation (NASDAQ:PDSB) (PDS Biotech or the Company), a clinical-stage immunotherapy company developing a growing pipeline of targeted cancer immunotherapies and infectious disease vaccines based on

PDSB

4 minute read

MEI Pharma Announces First Patient Dosed In Clinical Study Evaluating ME-344 Plus Bevacizumab In Patients With Previously Treated Metastatic Colorectal Cancer

By Happy Mohamed

August 16, 8:03 AM

MEI Pharma, Inc. (NASDAQ:MEIP), a clinical-stage pharmaceutical company focused on advancing new therapies for cancer, today announced the dosing of the first patient in a Phase 1b study evaluating ME-344 in combination

MEIP

6 minute read

Seagen Phase 3 Trial Of TUKYSA In Combination With Antibody-Drug Conjugate Ado-Trastuzumab Emtansine Meets Primary Endpoint Of Progression-Free Survival In Patients With Previously Treated HER2-Positive Metastatic Breast Cancer

By Happy Mohamed

August 16, 8:02 AM

Seagen Inc. (NASDAQ:SGEN) today announced that the Phase 3 HER2CLIMB-02 clinical trial of TUKYSA® (tucatinib) in combination with the antibody-drug conjugate ado-trastuzumab emtansine (Kadcyla®) met its

SGEN

1 minute read

Hess Midstream LP Announces Pricing Of $288M Secondary Public Offering Of 10M Class A Shares At A Price Of $28.80/Share

By Happy Mohamed

August 16, 12:19 AM

Hess Midstream LP (NYSE:HESM) ("HESM") today announced the pricing of an underwritten public offering of an aggregate 10,000,000 Class A shares representing limited partner interests in HESM by an affiliate of

HESM

1 minute read

AN2 Therapeutics Announces Pricing Of $70M Underwritten Offering Of 7,777,778 Shares Of Common Stock At A Price Of $9/Share

By Happy Mohamed

August 16, 12:17 AM

AN2 Therapeutics, Inc. (NASDAQ:ANTX), a clinical-stage biopharmaceutical company focused on developing treatments for rare, chronic, and serious infectious diseases with high unmet needs, today announced the pricing of

ANTX

1 minute read

Aramark Announces Filing Of Form 10 Registration Statement In Connection With Planned Spin-Off Of Aramark Uniform Services

By Happy Mohamed

August 15, 4:22 PM

Aramark (NYSE:ARMK) today announced that a Form 10 registration statement was filed with the U.S. Securities and Exchange Commission ("SEC") in connection with the previously announced spin-off of Aramark

ARMK

1 minute read

NANOBIOTIX Announces Expiration Of HSR Waiting Period Regarding The Agreement For Worldwide Co-Development And Commercialization Of Potential First-In-Class Radioenhancer NBTXR3

By Happy Mohamed

August 15, 4:19 PM

NANOBIOTIX (NASDAQ:NBTX), a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, announced today the expiration of the

NBTX

1 minute read

Vahanna Tech Edge Acquisition I Corp. Announces Effectiveness Of S-4 Registration Statement And August 25, 2023 Extraordinary General Meeting Of Shareholders To Approve Business Combination With Roadzen, Inc.

By Happy Mohamed

August 15, 4:17 PM

Vahanna Tech Edge Acquisition I Corp. (NASDAQ:VHNAU, VHNA, VHNAW)))) ("Vahanna"), a publicly traded special purpose acquisition company, today announced that it will hold an extraordinary general meeting of

RDZN

2 minute read

Diffusion Pharmaceuticals Stockholders Approve Merger With EIP Pharma; ~71% Of Stockholders Voted In Favor Of The Transaction; Announces 1-For-1.5 Reverse Stock Split

By Happy Mohamed

August 15, 4:13 PM

Approximately 71% of Stockholders Voted in Favor of the Transaction Diffusion Announces 1-for-1.5 Reverse Stock Split Merger on Track to Close on August 16, 2023 CHARLOTTESVILLE, Va., Aug. 15, 2023 (GLOBE

DFFN